| Patent Number |
Title Of Patent |
Date Issued |
| D319985 |
Measuring scoop |
September 17, 1991 |
|
| 6762295 |
Protective helicobacter antigens |
July 13, 2004 |
| Protective Helicobacter antigens, especially H. pylori antigens, and the use of these antigens for the treatment of or prevention of, gastroduodenal disease associated with H. pylori infection. |
| 6663873 |
Antigenic preparation for treatment or prevention of helicobacter infection |
December 16, 2003 |
| An antigenic preparation for use in the treatment or prevention of Helicobacter infection in a mammalian host, comprises the lipopolysaccharide (LPS) of Helicobacter bacteria, particularly the LPS of H. pylori or H. felis, or an immunogenic fragment thereof. |
| 6630582 |
Treatment and prevention of helicobacter infection |
October 7, 2003 |
| An antigenic preparation for use in the treatment or prevention of Helicobacter infection in a mammalian host, comprises the catalase enzyme of Helicobacter bacteria, particularly the catalase enzyme of H. pylori or H. felis, or an immunogenic fragment thereof. |
| 6599509 |
Compositions and methods comprising helicobacter antigens for treatment and prevention of inflam |
July 29, 2003 |
| The treatment of IBD in mammals, including humans, is described. More particularly, the present invention relates to compositions and methods for the treatment of IBD associated with Helicobacter or other bacterial infections in mammals, including humans, and to vaccine compositions and |
| 6468545 |
Treatment and prevention of helicobacter infection |
October 22, 2002 |
| An antigenic preparation for use in the treatment of prevention of Helicobacter infection in a mammalian host, comprises the catalase enzyme of Helicobacter bacterial, particularly the catalase enzyme of H. pylori or H. felis, or an immunogenic fragment thereof. |
| 6406703 |
Treatment of H. pylori associated gastroduodenal disease |
June 18, 2002 |
| The application discloses a method for the treatment of Heliobacter infection in a mammalian host, which comprises administration to said infected host of an immunologically effective amount of one or more Heliobacter antigen(s), optionally in association with a mucosal adjuvant. |
| 6129923 |
Treatment of H. pylori associated gastroduodenal disease |
October 10, 2000 |
| The application discloses a method for the treatment of Heliobacter infection in a mammalian host, which comprises administration to said infected host of an immunologically effective amount of one or more Heliobacter antigen(s), optionally in association with a mucosal adjuvant. |
| 6005090 |
Treatment and prevention of helicobacter infection |
December 21, 1999 |
| An antigenic preparation for use in the treatment or prevention of Helicobacter infection in a mammalian host, comprises the catalase enzyme of Helicobacter bacteria, particularly the catalase enzyme of H. pylori or H. felis, or an immunogenic fragment thereof. |
| 5871749 |
Therapeutic treatment of H. pylori associated gastroduodenal disease |
February 16, 1999 |
| The application discloses a method for the treatment of Heliobacter infection in a mammalian host, which comprises administration to said infected host of an immunologically effective amount of one or more Heliobacter antigen(s), optionally in association with a mucosal adjuvant. |
